Recent Patents on CNS Drug Discovery

Aims & Scope

Recent Patents on CNS Drug Discovery publishes review and research articles, drug clinical trial studies and guest edited thematic issues on recent patents in the field of CNS drug discovery e.g. novel bioactive compounds, analogs & targets. A selection of important and recent patents on CNS drug discovery is also included in the journal. The journal is essential reading for all researchers involved in CNS drug design and discovery. The journal also covers recent research (where patents have been registered) in fast emerging therapeutic areas/targets & therapeutic agents related to CNS Drug Discovery.

"The new journal on Recent Patents on CNS Drug Discovery is an important patent journal in the field of CNS Drug Discovery, which should provide research scientists in the field with recent developments in various frontier areas. The journal is strongly recommended to the scientific community."

Robert Huber
Nobel Laureate

Related Journals

Anti-Cancer Agents in Medicinal Chemistry aims to cover all the latest and outstanding developments in medicinal chemistry and rational drug design for the discovery of anti-cancer agents.

The journal Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry publishes expert reviews, original research articles, drug clinical trial studies and special topic issues.

Current Computer-Aided Drug Design aims to publish all the latest developments in drug design based on computational techniques. The field of computer-aided drug design has had extensive impact in the area of drug design.

Combinatorial Chemistry & High Throughput Screening is a high impact factor journal, having an impact factor 1.041, and is indexed by all major indexing agencies.

The journal Current Drug Safety publishes frontier articles on all the latest advances on drug safety.

The journal Current Clinical Pharmacology publishes frontier reviews on all the latest advances in clinical pharmacology.

Current Drug Targets is essential reading for all pharmaceutical scientists involved in drug discovery and development.

Current Drug Metabolism is an essential journal for academic, clinical, government and pharmaceutical scientists who wish to be kept informed and up-to-date with the latest and most important developments in this field.

Current Drug Delivery journal is essential reading for all pharmaceutical scientists involved in drug design, development and delivery.

Current Organic Chemistry is a high impact factor journal, having an impact factor 1.949, and is indexed by all major indexing agencies.

Cardiovascular & Hematological Agents in Medicinal Chemistry aims to cover all the latest and outstanding developments in medicinal chemistry and rational drug design for the discovery of new Cardiovascular & Hematological Agents.

Cardiovascular & Hematological Disorders-Drug is essential reading for all pharmaceutical scientists involved in drug discovery and development.

Current Molecular Medicine is a high impact factor journal, having an impact factor 3.621 and is indexed by all major indexing agencies.

Current Medicinal Chemistry covers all the latest and outstanding developments in medicinal chemistry and rational drug design.

Current Nanoscience is a high impact factor journal and is essential reading to all involved in nanoscience and its applied areas.

Current Pharmaceutical Design covers all subject areas of major importance to modern drug design including: medicinal chemistry, pharmacology, drug targets and disease mechanism.

Current Pharmaceutical Analysis provides convincing and state-of-the-art reviews and original research articles to Pharmaceutical and Biomedical scientists.

Central Nervous System Agents in Medicinal Chemistry aims to cover all the latest and outstanding developments in medicinal chemistry and rational drug design for the discovery of new central nervous system agents.

Current Topics in Medicinal Chemistry is essential reading for every medicinal chemist who wishes to be kept informed with the latest developments in medicinal chemistry and in other allied disciplines.

Current Protein & Peptide Science is a high impact factor journal and is indexed by all major indexing agencies.

Recent Patents on Anti-Cancer Drug Discovery is essential reading for all researchers involved in anti-cancer drug design and discovery.

The journal Recent Patents on Anti-Infective Drug Discovery is essential reading for all researchers involved in anti-infective drug design and discovery.

Medicinal Chemistry is a peer-reviewed journal and aims to cover all the latest outstanding developments in medicinal chemistry and rational drug design.

Protein and Peptide Letters provides an excellent venue for communication of succinct reports of interesting research findings.

The journal Infectious Disorders - Drug Targets is essential reading for all pharmaceutical scientists involved in drug design, discovery and development.

Mini-Reviews in Medicinal Chemistry publishes short reviews on the important recent developments in medicinal chemistry and allied disciplines.

Letters in Drug Design & Discovery is essential reading for all pharmaceutical scientists involved in drug design and discovery.

The journal Endocrine, Metabolic & Immune Disorders-Drug Targets publishes timely reviews of experimental and clinical studies in the field of endocrine, metabolic, and immune disorders.

Current Stem Cell Research & Therapy is a high impact factor journal, and is essential reading for all researchers & clinicians involved in stem cells research.

The journal Reviews on Recent Clinical Trials publishes frontier reviews, original research articles, drug clinical trial studies and guest edited thematic issues on recent clinical trials of major importance.

Current Alzheimer Research publishes peer-reviewed reviews, research, drug clinical trial studies and letter articles on all areas of Alzheimer’s disease.

Current HIV Research is a high impact factor journal and is essential reading for all the stakeholders involved in HIV research.

The journal Current Drug Discovery Technologies publishes comprehensive overviews of all the major modern techniques and technologies used in drug design and discovery.

CNS & Neurological Disorders - Drug Targets is a high impact factor journal and is essential reading for all pharmaceutical scientists involved in drug discovery and development.

Current Proteomics publishes well-timed review articles on topics relevant and significant to the development of proteomics.

The journal Drug Metabolism Letters is widely read journal in its field, and is indexed by all the major indexing agencies. This journal is essential reading for all the researchers involved in drug metabolism and disposition studies

The journal Recent Patents on Drug Delivery & Formulation is essential reading for all researchers involved in the fields of drug delivery and formulation

The journal Recent Patents on Endocrine, Metabolic & Immune Drug Discovery is essential reading for all researchers involved in endocrine, metabolic and immune drug design and discovery

The journal Recent Patents on Inflammation & Allergy Drug Discovery is essential reading for all researchers involved in inflammation and allergy drug design and discovery.

Current Drug Target -Infectious Disorders

The journal Current Drug Abuse is of interest to a broad audience in its field, and is indexed by all the major indexing agencies

The journal Current Radiopharmaceuticals is essential reading for all the researchers involved in this field, and this journal is indexed by all the major indexing agencies

The journal Current Aging Science is essential reading for researchers, educators and physicians with interest in aging, age-related dementia and Alzheimer’s disease and longevity.

The journal Pharmaceutical Nanotechnology is essential reading for all the researchers involved in pharmaceutical implications of the nanotechnology.

The goal of this journal is to establish a new forum for this interdisciplinary field so that neuroscientists and biomedical engineers can publish their research works in one periodical. NBE is devoted to bridge the gap between Neuroscience and Biomedical Engineering, and to foster the mutual understanding in both fields.

Related E-Books

Bentham ebook::Anti-Angiogenesis Drug Discovery and Development

Bentham ebook::Anti-Obesity Drug Discovery and Development

Bentham ebook::Frontiers in Anti-Cancer Drug Discovery

Bentham ebook::Frontiers in Cardiovascular Drug Discovery

Bentham ebook::Frontiers in CNS Drug Discovery

Bentham ebook::Frontiers in Drug Design and Discovery

Bentham ebook::Drug Design and Discovery in Alzheimer’s Disease

Bentham ebook::Erythropoietic Stimulating Agents

Bentham ebook::The 1 International Conference on Drug Design and Discovery February 4 - 7, 2008, Dubai, UAE

Bentham ebook::The Search for Antidepressants - An Integrative View of Drug Discovery

Bentham ebook::Translational Animal Models in Drug Discovery and Development

Bentham ebook::Methods to Determine Enzymatic Activity

Bentham ebook::Rab GTPases and Membrane Trafficking

Bentham ebook::Alzheimer's Disease: Pathological and Clinical Findings

Bentham ebook::Advances in Alzheimer Research

Bentham ebook::Advances in Alzheimer’s Research

Bentham ebook::Cellular and Molecular Biology of Autism Spectrum Disorders

Bentham ebook::Cellular Mechanisms in Alzheimer’s Disease

Bentham ebook::Chemical-Induced Seizures: Mechanisms, Consequences and Treatment

Bentham ebook::Classical Neurotransmitters and Neuropeptides Involved in Schizoaffective Disorder: Focus on Prophylactic Medication

Bentham ebook::Contemporary Sleep Medicine-For Patients

Bentham ebook::Contemporary Sleep Medicine-For Physicians

Bentham ebook::Craniopharyngiomas − Classification and Surgical Treatment

Bentham ebook::Frontiers in Clinical Drug Research – Alzheimer Disorders

Bentham ebook::Frontiers in Clinical Drug Research - Alzheimer Disorder

Bentham ebook::Frontiers in Clinical Drug Research- Central Nervous System

Bentham ebook::Frontiers in Clinical Drug Research - CNS and Neurological Disorders

Bentham ebook::NeuroEndovascular Challenges

Bentham ebook::Video Atlas of Spine Surgical Techniques

Bentham ebook::Brain Ischemic Stroke - From Diagnosis to Treatment

Bentham ebook::How Selegiline ((-)-Deprenyl) Slows Brain Aging

Bentham ebook::Hypotheses and Dynamics in the Pathogenesis of Neurodegenerative Disorders

Bentham ebook::Language Disturbances in Adulthood: New Advances from the Neurolinguistics Perspective

Bentham ebook::Manual of Child Neurology: Problem Based Approach to Common Disorders

Bentham ebook::Molecular Aspects of Neurodegeneration and Neuroprotection

Bentham ebook::Network Approaches to Diseases of the Brain

Bentham ebook::New Concepts in Stroke Diagnosis and Therapy

Bentham ebook::New Non-opioid Analgesics: Understanding Molecular Mechanisms on the Basis of Patch-clamp and Quantum-chemical Studies

Bentham ebook::Pain: Causes, Concerns and Consequences

Bentham ebook::Protein Misfolding Disorders: A Trip into the ER

Bentham ebook::Common Pathogenic Mechanisms between Down Syndrome and Alzheimer's Disease: Steps toward Therapy

Bentham ebook::Chronic Diseases in Geriatric Patients

Bentham ebook::An Interdisciplinary Approach to Geriatric Medicine

Bentham ebook::Understanding Stroke in a Global Context

Bentham ebook::Young Perspectives for Old Diseases

Bentham Science: About Us

Bentham Science is a science, technology, and medical (STM) publisher, providing academic researchers and industrial professionals with the latest information in diverse fields of science and technology. Our peer-reviewed scholarly journals and books have an ever-increasing readership of millions of researchers worldwide.

Bentham Science currently publishes more than 100 journals in both electronic and printed formats. Our journals cover various disciplines in pharmaceutical research and development, medical subspecialties, engineering, technology, and social sciences. The journals are indexed in recognized indexing agencies, such as Journal Citation Reports/Science Edition, MEDLINE/Index Medicus, PubMed, Scopus, Chemical Abstracts, EMBASE. ... Read More

Welcome To
Recent Patents on CNS Drug Discovery

About the Journal

Aims & Scope

Meet Our Editorial Board Member

Editorial (Thematic Issue: From Old Cannabinoids to Emerging New Synthetic Derivatives with Potential Therapeutic Application in Neurological Disorders)

Peptide Agonists and Antagonists with Potential Application in Neurological Disorders

Endocannabinoid System in Neurological Disorders

Immuno-Modulatory Properties of a Quinolin-2-(1H)-on-3-Carboxamide Derivative: Relevance in Multiple Sclerosis

Beyond the Direct Activation of Cannabinoid Receptors: New Strategies to Modulate the Endocannabinoid System in CNS-Related Diseases

Synthetic Cannabinoid Receptor Agonists and Antagonists: Implication in CNS Disorders

Phytocannabinoids and Cannabimimetic Drugs: Recent Patents in Central Nervous System Disorders

Cannabinoids and Neuro-Inflammation: Regulation of Brain Immune Response

Neuropharmacological Properties of Withania somnifera - Indian Ginseng: An Overview on Experimental Evidence with Emphasis on Clinical Trials and Patents

Patent Selections

Acknowledgements to Reviewers

Farewell Note

Endorsement(s)

Announcements

Related Journals

Related E-Books

About the Publisher

Bentham Science: About Us

Indexed in

Welcome To Recent Patents on CNS Drug Discovery

About the Journal

Aims & Scope

Meet Our Editorial Board Member

Editorial (Thematic Issue: From Old Cannabinoids to Emerging New Synthetic Derivatives with Potential Therapeutic Application in Neurological Disorders)

Peptide Agonists and Antagonists with Potential Application in Neurological Disorders

Endocannabinoid System in Neurological Disorders

Immuno-Modulatory Properties of a Quinolin-2-(1H)-on-3-Carboxamide Derivative: Relevance in Multiple Sclerosis

Beyond the Direct Activation of Cannabinoid Receptors: New Strategies to Modulate the Endocannabinoid System in CNS-Related Diseases

Synthetic Cannabinoid Receptor Agonists and Antagonists: Implication in CNS Disorders

Phytocannabinoids and Cannabimimetic Drugs: Recent Patents in Central Nervous System Disorders

Cannabinoids and Neuro-Inflammation: Regulation of Brain Immune Response

Neuropharmacological Properties of Withania somnifera - Indian Ginseng: An Overview on Experimental Evidence with Emphasis on Clinical Trials and Patents

Patent Selections

Acknowledgements to Reviewers

Farewell Note

Endorsement(s)

Announcements

Related Journals

Related E-Books

About the Publisher

Bentham Science: About Us

Indexed in

Welcome To
Recent Patents on CNS Drug Discovery